Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 25, 2017 Filed Sep 27, 2017 20:54 UTC |
Hamel Lawrence GChief Development Officer
|
SaleCommon Stock | 13,827 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-016405 · rdgdoc.xml · nonDerivative · entry 1 Hamel Lawrence G · CIK 0001511368 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 68,504 F2 · price: The Shares were sold in a range from $3.50-$4.50 F3 · balance_after: Non-reportable acquisition of 1,977 shares of Common Stock through the Company's Employee Stock Purchase Plan F1 · ownership.direct: 52,125 of the Shares are held in the Hamel Revocable Living Trust F1 · ownership.nature: 52,125 of the Shares are held in the Hamel Revocable Living Trust Read SEC document |
| September 11, 2017 Filed Sep 11, 2017 21:36 UTC |
ASADORIAN RAFFIChief Financial Officer
|
PurchaseCommon Stock | 7,000 | $3.24 | $22,705.20 |
DisclosureSEC source: 0001437749-17-015834 · rdgdoc.xml · nonDerivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 Read SEC document |
| August 24, 2017 Filed Aug 24, 2017 21:54 UTC |
EDWARDS MARK GDirector
|
PurchaseCommon Stock | 4,800 | $3.03 | $14,520.00 |
DisclosureSEC source: 0001437749-17-015259 · rdgdoc.xml · nonDerivative · entry 2 EDWARDS MARK G · CIK 0001190429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Read SEC document |
| August 24, 2017 Filed Aug 24, 2017 22:14 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
PurchaseCommon Stock | 15,000 | $3.00 | $45,000.00 |
DisclosureSEC source: 0001437749-17-015261 · rdgdoc.xml · nonDerivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| August 22, 2017 Filed Aug 22, 2017 21:19 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
PurchaseCommon Stock | 10,000 | $2.95 | $29,487.00 |
DisclosureSEC source: 0001437749-17-015179 · rdgdoc.xml · nonDerivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,801 F1 · price: This is a weighted average purchase price. Shares were purchased in the range of $2.9250 and $2.95. F2 · balance_after: Balance includes non-reportable acquisition of 6,786 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| August 22, 2017 Filed Aug 24, 2017 21:54 UTC |
EDWARDS MARK GDirector
|
PurchaseCommon Stock | 200 | $2.90 | $580.00 |
DisclosureSEC source: 0001437749-17-015259 · rdgdoc.xml · nonDerivative · entry 1 EDWARDS MARK G · CIK 0001190429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,200 Read SEC document |
| August 16, 2017 Filed Aug 17, 2017 13:03 UTC |
ASADORIAN RAFFIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001437749-17-014929 · rdgdoc.xml · derivative · entry 1 ASADORIAN RAFFI · CIK 0001628970 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2027-08-15 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (August 16, 2018) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| June 19, 2017 Filed Jun 21, 2017 20:45 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
SaleCommon Stock | 875,000 | $2.40 | $2,100,000.00 |
DisclosureSEC source: 0001012975-17-000494 · edgar.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 4,533,728 F1 · ownership.nature: The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 21:17 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001437749-17-011357 · rdgdoc.xml · derivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-14 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 21:16 UTC |
HOFFMAN C STEVENDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001437749-17-011356 · rdgdoc.xml · derivative · entry 1 HOFFMAN C STEVEN · CIK 0001190482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-14 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 21:15 UTC |
Rosen Howard BDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001437749-17-011355 · rdgdoc.xml · derivative · entry 1 Rosen Howard B · CIK 0001307068 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-14 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 21:15 UTC |
WAN MARK ADirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001437749-17-011354 · rdgdoc.xml · derivative · entry 1 WAN MARK A · CIK 0001190472 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-14 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 21:13 UTC |
Afable RichardDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001437749-17-011353 · rdgdoc.xml · derivative · entry 1 Afable Richard · CIK 0001594021 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-14 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| June 15, 2017 Filed Jun 15, 2017 21:13 UTC |
EDWARDS MARK GDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001437749-17-011352 · rdgdoc.xml · derivative · entry 1 EDWARDS MARK G · CIK 0001190429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-14 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| June 15, 2017 Filed Feb 7, 2019 22:33 UTC |
HOFFMAN STEPHEN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001209191-19-008170 · doc5.xml · derivative · entry 4 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-14 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · security: Transactions were previously reported on Form 4, but were inadvertently filed using incorrect CIK and CCC numbers which resulted in the reports appearing incorrectly as a report of a person different from the Reporting Person. This Form 5 is being filed to identify correctly these past transactions as the Reporting Person's transactions and to reflect accurately the Reporting Person's beneficial ownership holdings in the Issuer. F4 · derivative.exercise_date: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service on the Company's Board of Directors. F5 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| April 10, 2017 Filed Apr 11, 2017 21:29 UTC |
Hamel Lawrence GChief Development Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 9,122 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001437749-17-006460 · rdgdoc.xml · derivative · entry 3 Hamel Lawrence G · CIK 0001511368 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,122 shares Expires 2017-12-05 F2 · derivative.exercise_date: Options vest as follows: 1/4 of the shares subject to the option vest on December 4, 2008 with the remaining shares subject to the option vesting on an equal monthly basis over 36 months. Read SEC document |
| April 10, 2017 Filed Apr 11, 2017 21:29 UTC |
Hamel Lawrence GChief Development Officer
|
GrantCommon Stock | 6,879 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-17-006460 · rdgdoc.xml · nonDerivative · entry 2 Hamel Lawrence G · CIK 0001511368 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,354 F1 · price: Non-reportable acquisition of 6,879 shares of Common Stock through the Company's Employee Stock Purchase Plan. Read SEC document |
| April 10, 2017 Filed Apr 11, 2017 21:29 UTC |
Hamel Lawrence GChief Development Officer
|
GrantCommon Stock | 9,122 | $1.20 | $10,946.40 |
DisclosureSEC source: 0001437749-17-006460 · rdgdoc.xml · nonDerivative · entry 1 Hamel Lawrence G · CIK 0001511368 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,475 Read SEC document |
| March 06, 2017 Filed Mar 7, 2017 21:35 UTC |
Angotti Vincent J.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 800,000 | $0.00 Strike: $3.30 | $0.00 |
DisclosureSEC source: 0001437749-17-003950 · rdgdoc.xml · derivative · entry 1 Angotti Vincent J. · CIK 0001700225 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2027-03-05 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (March 6, 2018) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. F3 · derivative.exercise_date: The shares have double-trigger acceleration on a change of control Read SEC document |
| February 07, 2017 Filed Feb 10, 2017 01:53 UTC |
Palmer Pamela PDirector · Chief Medical Officer
|
GrantCommon Stock (Right to Buy) · Derivative | 132,500 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001437749-17-002062 · rdgdoc.xml · derivative · entry 1 Palmer Pamela P · CIK 0001511365 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,500 Underlying: Common Stock · 132,500 shares Expires 2028-02-06 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| February 07, 2017 Filed Feb 10, 2017 02:03 UTC |
Hamel Lawrence GChief Development Officer
|
GrantCommon Stock (Right to Buy) · Derivative | 79,500 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001437749-17-002067 · rdgdoc.xml · derivative · entry 1 Hamel Lawrence G · CIK 0001511368 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,500 Underlying: Common Stock · 79,500 shares Expires 2028-02-06 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| February 07, 2017 Filed Feb 10, 2017 01:57 UTC |
MORRIS TIMOTHY EChief Financial Officer
|
GrantCommon Stock (Right to Buy) · Derivative | 112,500 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001437749-17-002066 · rdgdoc.xml · derivative · entry 1 MORRIS TIMOTHY E · CIK 0001191286 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 112,500 shares Expires 2028-02-06 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| February 07, 2017 Filed Feb 10, 2017 01:57 UTC |
Dasu Badri NChief Engineering Officer
|
GrantCommon Stock (Right to Buy) · Derivative | 79,500 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001437749-17-002065 · rdgdoc.xml · derivative · entry 1 Dasu Badri N · CIK 0001310803 · Chief Engineering Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,500 Underlying: Common Stock · 79,500 shares Expires 2028-02-06 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| February 07, 2017 Filed Feb 10, 2017 01:54 UTC |
Wright-Mitchell JaneChief Legal Officer
|
GrantCommon Stock (Right to Buy) · Derivative | 79,500 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001437749-17-002063 · rdgdoc.xml · derivative · entry 1 Mitchell Jane Wright · CIK 0001614568 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,500 Underlying: Common Stock · 79,500 shares Expires 2028-02-06 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2017) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| February 07, 2017 Filed Feb 18, 2017 01:09 UTC |
Rosen Howard BDirector · CEO
|
GrantStock Option (Right to Buy) · Derivative | 366,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001437749-17-002807 · rdgdoc.xml · derivative · entry 1 Rosen Howard B · CIK 0001307068 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,000 Underlying: Common Stock · 366,000 shares Expires 2028-02-06 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date (February 7, 2016) and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months. F3 · derivative.exercise_date: 100% Acceleration upon Change of Control. Read SEC document |
| September 29, 2016 Filed Sep 30, 2016 20:32 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
SaleCommon Stock | 97,200 | $3.88 | $377,116.56 |
DisclosureSEC source: 0001019056-16-001565 · acelrx_4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,386,410 F1 · ownership.nature: This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of Master Fund and to a managed account (the "Managed Account") for Titan Perc, Ltd. Mr. Edelman is the managing member of the Advisor. F2 · ownership.nature: This amount reflects the amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 28, 2016 Filed Sep 30, 2016 20:32 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
SaleCommon Stock | 119,300 | $3.96 | $472,380.28 |
DisclosureSEC source: 0001019056-16-001565 · acelrx_4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,483,610 F1 · ownership.nature: This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of Master Fund and to a managed account (the "Managed Account") for Titan Perc, Ltd. Mr. Edelman is the managing member of the Advisor. F2 · ownership.nature: This amount reflects the amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 20:37 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
SaleCommon Stock | 115,923 | $3.63 | $420,510.68 |
DisclosureSEC source: 0001019056-16-001549 · acelrx_4.xml · nonDerivative · entry 2 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,602,910 F1 · ownership.nature: This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of Master Fund and to a managed account (the "Managed Account") for Titan Perc, Ltd. Mr. Edelman is the managing member of the Advisor. F2 · ownership.nature: This amount reflects the amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 20:37 UTC |
PERCEPTIVE ADVISORS LLC10% owner
EDELMAN JOSEPH10% owner
|
SaleCommon Stock | 276,927 | $3.73 | $1,032,300.78 |
DisclosureSEC source: 0001019056-16-001549 · acelrx_4.xml · nonDerivative · entry 1 PERCEPTIVE ADVISORS LLC · CIK 0001224962 · 10% owner EDELMAN JOSEPH · CIK 0001164426 · 10% owner PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · CIK 0001249675 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 5,718,833 F1 · ownership.nature: This Form 4 is being filed by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"), Perceptive Advisors LLC (the "Advisor") and Joseph Edelman. The Advisor serves as the investment manager of Master Fund and to a managed account (the "Managed Account") for Titan Perc, Ltd. Mr. Edelman is the managing member of the Advisor. F2 · ownership.nature: This amount reflects the amount of securities held by the Master Fund and the Managed Account immediately following the transaction requiring the filing of this statement. In accordance with Instruction 5(b)(iv) of Form 4, the entire amount of the Issuer's securities held by Master Fund and the Managed Account is reported herein. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. Read SEC document |
| June 21, 2016 Filed Feb 7, 2019 22:33 UTC |
HOFFMAN STEPHEN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $2.87 | $0.00 |
DisclosureSEC source: 0001209191-19-008170 · doc5.xml · derivative · entry 3 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2026-06-20 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · security: Transactions were previously reported on Form 4, but were inadvertently filed using incorrect CIK and CCC numbers which resulted in the reports appearing incorrectly as a report of a person different from the Reporting Person. This Form 5 is being filed to identify correctly these past transactions as the Reporting Person's transactions and to reflect accurately the Reporting Person's beneficial ownership holdings in the Issuer. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| June 23, 2015 Filed Feb 7, 2019 22:33 UTC |
HOFFMAN STEPHEN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001209191-19-008170 · doc5.xml · derivative · entry 2 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2025-06-22 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · security: Transactions were previously reported on Form 4, but were inadvertently filed using incorrect CIK and CCC numbers which resulted in the reports appearing incorrectly as a report of a person different from the Reporting Person. This Form 5 is being filed to identify correctly these past transactions as the Reporting Person's transactions and to reflect accurately the Reporting Person's beneficial ownership holdings in the Issuer. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| July 24, 2014 Filed Feb 7, 2019 22:33 UTC |
HOFFMAN STEPHEN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $10.22 | $0.00 |
DisclosureSEC source: 0001209191-19-008170 · doc5.xml · derivative · entry 1 HOFFMAN STEPHEN J · CIK 0001190418 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2024-07-23 F1 · security: Issued pursuant to the 2011 Equity Incentive Plan. F2 · security: Transactions were previously reported on Form 4, but were inadvertently filed using incorrect CIK and CCC numbers which resulted in the reports appearing incorrectly as a report of a person different from the Reporting Person. This Form 5 is being filed to identify correctly these past transactions as the Reporting Person's transactions and to reflect accurately the Reporting Person's beneficial ownership holdings in the Issuer. F3 · derivative.exercise_date: Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.